Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bladder cancer: Present and future.

Literature DB >> 28736063

Bladder cancer: Present and future.

Roberto Hugo Martinez Rodriguez¹, Oscar Buisan Rueda², Luis Ibarz².

Abstract

Bladder cancer has a high incidence and involves high associated morbidity and mortality. Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment involve different medical specialties. For this reason, we consider it important to spread the current consensus for its management. Recent advances in immunology and Chemotherapy make it necessary to expose and reflect on future perspectives.

Entities: Disease

Keywords: Bacilo Calmette-Guérin; Bladder cancer; Calmette-Guérin bacillus; Cistectomía; Cystectomy; Haematuria; Hematuria; Immunotherapy; Inmunoterapia; Tumor vesical; Urotelio; Urothelial

Mesh：

Substances：
Biomarkers, Tumor

Year: 2017 PMID： 28736063 DOI： 10.1016/j.medcli.2017.06.009

Source DB: PubMed Journal: Med Clin (Barc) ISSN： 0025-7753 Impact factor: 1.725

Keyword Cloud
Cited

41 in total

1. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.

Authors: Xiancheng Han; Jing Liu; Yongguo Liu; Linkai Mou; Chunlong Li
Journal: Cancer Manag Res Date: 2021-06-01 Impact factor: 3.989

2. Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.

Authors: Chaozhi Tang; Meng Yu; Jiakang Ma; Yuyan Zhu
Journal: J Transl Med Date: 2021-05-13 Impact factor: 5.531

3. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.

Authors: Zhongyuan Liu; Dalong Xie; Hui Zhang
Journal: Cell Death Dis Date: 2018-10-11 Impact factor: 8.469

4. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.

Authors: Cong Zhang; Xiangping Chang; Dongshan Chen; Feilong Yang; Zeyan Li; Dawei Li; Nengwang Yu; Lei Yan; Hainan Liu; Zhonghua Xu
Journal: Cancer Manag Res Date: 2019-08-22 Impact factor: 3.989

5. Integrating random walk with restart and k-Nearest Neighbor to identify novel circRNA-disease association.

Authors: Xiujuan Lei; Chen Bian
Journal: Sci Rep Date: 2020-02-06 Impact factor: 4.379

6. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.

Authors: Xianping Che; Jiangtao Zhan; Fan Zhao; Zunhe Zhong; Mianchuan Chen; Ruifa Han; Yi Wang
Journal: Biomed Res Int Date: 2021-07-05 Impact factor: 3.411

Bladder cancer: Present and future.

1. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.

2. Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.

3. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.

4. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.

5. Integrating random walk with restart and k-Nearest Neighbor to identify novel circRNA-disease association.

6. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.

7. YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.

8. CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer.

9. Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma.

10. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.